{"id":66744,"date":"2026-04-24T16:51:37","date_gmt":"2026-04-24T11:21:37","guid":{"rendered":"https:\/\/johnsonfrancis.org\/professional\/?p=66744"},"modified":"2026-04-24T16:51:39","modified_gmt":"2026-04-24T11:21:39","slug":"emerging-biomarkers-in-cardiology","status":"publish","type":"post","link":"https:\/\/johnsonfrancis.org\/professional\/emerging-biomarkers-in-cardiology\/","title":{"rendered":"Emerging Biomarkers in Cardiology"},"content":{"rendered":"<iframe loading=\"lazy\" width=\"560\" height=\"315\" src=\"https:\/\/www.youtube.com\/embed\/6eFlaB3fxI4?si=rdjbdabq7hJnonUN\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n\n<p id=\"p-rc_5bcb41b524706ca2-19\" class=\"wp-block-paragraph\">The landscape of cardiac biomarkers is shifting from simple &#8220;damage detection&#8221; (like Troponin) to &#8220;pathophysiological profiling.&#8221; For a clinician focusing on diagnostics, the most relevant newer biomarkers are those that help phenotype complex conditions like HFpEF, ATTR-CM, and PVC-induced cardiomyopathy.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">1. Advanced Heart Failure &amp; Myocardial Remodeling<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">While NT-proBNP remains the workhorse, newer markers provide insights into <strong>fibrosis<\/strong> and <strong>mechanical strain<\/strong>, which are crucial for prognosticating patients who may be &#8220;biochemically stable&#8221; but structurally worsening.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5572469\/\" type=\"link\" id=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5572469\/\">Soluble ST2 (sST2)<\/a>:<\/strong> A marker of mechanical stretch and fibrosis. Unlike BNP, it is remarkably stable, not significantly affected by age, BMI, or renal function. High levels (>35 ng\/mL) strongly predict hospitalization and death across HFrEF and HFpEF.<\/li>\n\n\n\n<li class=\"\"><strong><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7731136\/\" type=\"link\" id=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7731136\/\">Galectin-3<\/a>:<\/strong> Reflects active macrophage-mediated fibrosis. It is particularly useful for identifying patients who will experience rapid remodeling.<\/li>\n\n\n\n<li class=\"\"><strong>MR-proADM (Mid-regional pro-adrenomedullin):<\/strong> A major 2026 update (<em><a href=\"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCULATIONAHA.125.077833\" type=\"link\" id=\"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCULATIONAHA.125.077833\">Circulation 31 March 2026<\/a><\/em>) highlights its utility in <strong>Transthyretin Amyloid Cardiomyopathy (ATTR-CM)<\/strong>. MR-proADM is a superior predictor of mortality and heart failure events in ATTR-CM compared to traditional markers.<\/li>\n\n\n\n<li class=\"\"><strong><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7897243\/\" type=\"link\" id=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7897243\/\">GDF-15 (Growth Differentiation Factor-15)<\/a>:<\/strong> A &#8220;stress-response&#8221; cytokine linked to inflammation and oxidative stress. It is increasingly used in <a href=\"https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(16)00741-8\/abstract\" type=\"link\" id=\"https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(16)00741-8\/abstract\">multi-marker panels to predict bleeding risk<\/a> in patients on anticoagulants and overall mortality in chronic heart failure.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">2. Arrhythmias &amp; PVC-Induced Cardiomyopathy<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">There is emerging data on how to predict which patients with a high PVC burden will develop LV dysfunction.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>Inflammatory Transcriptional Markers:<\/strong> Research published in January 2026 (<em><a href=\"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCEP.125.014195\">Circulation: Arrhythmia and Electrophysiology<\/a><\/em>) suggests that high PVC burden upregulates <strong>IL-1\u03b2<\/strong> and the <strong>NF-\u03baB<\/strong> (Nuclear Factor kappa-light-chain-enhancer of activated B cells) signaling pathway. These markers of &#8220;smoldering inflammation&#8221; may soon provide a biochemical rationale for early ablation in asymptomatic patients with a high burden before LVEF drops.<\/li>\n\n\n\n<li class=\"\"><strong>MicroRNAs (miRNA-208b, miRNA-9):<\/strong> Being studied as specific markers for ventricular remodeling that could differentiate &#8220;benign&#8221; PVCs from those causing structural damage at a molecular level. A recent report noted that these miRNAs may serve as <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/41595522\/\" type=\"link\" id=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/41595522\/\">early predictive biomarkers for Pacing Induced Cardiomyopathy<\/a>. Early deterioration of left ventricular global longitudinal strain and expression of these miRNAs preceded overt left ventricular systolic dysfunction.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">3. Valvular &amp; Structural Heart Disease<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>Lipoprotein(a) in Aortic Stenosis:<\/strong> Beyond its role in atherosclerosis, high Lp(a) is now recognized as a primary driver of calcific aortic valve disease progression. In patients with calcific aortic stenosis, Lp(a) levels predicted a higher risk of valvular and cardiovascular outcomes (<em><a href=\"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.124.038955\" type=\"link\" id=\"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.124.038955\">JAHA 2025<\/a><\/em>).<\/li>\n\n\n\n<li class=\"\"><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12820923\/\" type=\"link\" id=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12820923\/\"><strong>Matrix Metalloproteinases (MMP\u20109<\/strong>)<\/a><strong>:<\/strong> Used as an exploratory marker for extracellular matrix turnover, providing a window into the &#8220;transition&#8221; from compensated hypertrophy to heart failure in patients with severe AS.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">4. The Multi-Omics &amp; AI Frontier<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The &#8220;newer&#8221; biomarker is often not a single protein, but a <strong>proteomic or metabolomic signature<\/strong>.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>Proteomic Panels:<\/strong> Instead of one marker, researchers are now validating <a href=\"https:\/\/academic.oup.com\/eurheartj\/article\/41\/41\/3998\/5893663?login=false\" type=\"link\" id=\"https:\/\/academic.oup.com\/eurheartj\/article\/41\/41\/3998\/5893663?login=false\">panels of 50+ proteins<\/a>. These signatures can predict the 10-year <a href=\"https:\/\/academic.oup.com\/eurjpc\/article\/31\/14\/1681\/7636607?login=false\" type=\"link\" id=\"https:\/\/academic.oup.com\/eurjpc\/article\/31\/14\/1681\/7636607?login=false\">risk of a Major Adverse Cardiovascular Event (MACE)<\/a> more accurately than clinical risk scores.<\/li>\n\n\n\n<li class=\"\"><strong>Gut Microbiome Metabolites (TMAO):<\/strong> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12938587\/\" type=\"link\" id=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12938587\/\">Trimethylamine N-oxide (TMAO)<\/a> is gaining traction as a biomarker for gut-heart axis health, directly linked to plaque stability and heart failure outcomes.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Summary Table for Clinical Application<\/h3>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><td><strong>Pathophysiology<\/strong><\/td><td><strong>Biomarker<\/strong><\/td><td><strong>Clinical Utility<\/strong><\/td><\/tr><\/thead><tbody><tr><td><strong>Myocardial Strain<\/strong><\/td><td><strong>sST2<\/strong><\/td><td>Prognosis in HF; independent of renal function.<\/td><\/tr><tr><td><strong>Active Fibrosis<\/strong><\/td><td><strong>Galectin-3<\/strong><\/td><td>Predicts rapid LV remodeling and HFpEF progression.<\/td><\/tr><tr><td><strong>Systemic Stress<\/strong><\/td><td><strong>GDF-15<\/strong><\/td><td>Risk stratification for bleeding\/mortality.<\/td><\/tr><tr><td><strong>Amyloidosis (ATTR)<\/strong><\/td><td><strong>MR-proADM<\/strong><\/td><td>Predictive of mortality in cardiac amyloidosis (2026 update).<\/td><\/tr><tr><td><strong>Early Ischemia<\/strong><\/td><td><strong><a href=\"https:\/\/johnsonfrancis.org\/professional\/copeptin-a-novel-biomarker-for-early-diagnosis-of-myocardial-infarction\/\" type=\"link\" id=\"https:\/\/johnsonfrancis.org\/professional\/copeptin-a-novel-biomarker-for-early-diagnosis-of-myocardial-infarction\/\">Copeptin<\/a><\/strong><\/td><td>Used with hs-cTn for rapid &#8220;one-draw&#8221; rule-out of MI.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The landscape of cardiac biomarkers is shifting from simple &#8220;damage detection&#8221; (like Troponin) to &#8220;pathophysiological profiling.&#8221; For a clinician focusing on diagnostics, the most relevant newer biomarkers are those that help phenotype complex conditions like HFpEF, ATTR-CM, and PVC-induced cardiomyopathy. 1. Advanced Heart Failure &amp; Myocardial Remodeling While NT-proBNP remains the workhorse, newer markers provide [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":66746,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","footnotes":""},"categories":[9],"tags":[],"class_list":["post-66744","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Emerging Biomarkers in Cardiology - All About Cardiovascular System and Disorders<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/johnsonfrancis.org\/professional\/emerging-biomarkers-in-cardiology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Emerging Biomarkers in Cardiology - All About Cardiovascular System and Disorders\" \/>\n<meta property=\"og:description\" content=\"The landscape of cardiac biomarkers is shifting from simple &#8220;damage detection&#8221; (like Troponin) to &#8220;pathophysiological profiling.&#8221; For a clinician focusing on diagnostics, the most relevant newer biomarkers are those that help phenotype complex conditions like HFpEF, ATTR-CM, and PVC-induced cardiomyopathy. 1. Advanced Heart Failure &amp; Myocardial Remodeling While NT-proBNP remains the workhorse, newer markers provide [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/johnsonfrancis.org\/professional\/emerging-biomarkers-in-cardiology\/\" \/>\n<meta property=\"og:site_name\" content=\"All About Cardiovascular System and Disorders\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-24T11:21:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-24T11:21:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/04\/Emerging-Biomarkers-in-Cardiology.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"676\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Johnson Francis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Johnson Francis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/emerging-biomarkers-in-cardiology\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/emerging-biomarkers-in-cardiology\\\/\"},\"author\":{\"name\":\"Johnson Francis\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"headline\":\"Emerging Biomarkers in Cardiology\",\"datePublished\":\"2026-04-24T11:21:37+00:00\",\"dateModified\":\"2026-04-24T11:21:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/emerging-biomarkers-in-cardiology\\\/\"},\"wordCount\":558,\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/emerging-biomarkers-in-cardiology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/Emerging-Biomarkers-in-Cardiology.jpg\",\"articleSection\":[\"General Cardiology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/emerging-biomarkers-in-cardiology\\\/\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/emerging-biomarkers-in-cardiology\\\/\",\"name\":\"Emerging Biomarkers in Cardiology - All About Cardiovascular System and Disorders\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/emerging-biomarkers-in-cardiology\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/emerging-biomarkers-in-cardiology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/Emerging-Biomarkers-in-Cardiology.jpg\",\"datePublished\":\"2026-04-24T11:21:37+00:00\",\"dateModified\":\"2026-04-24T11:21:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/emerging-biomarkers-in-cardiology\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/emerging-biomarkers-in-cardiology\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/emerging-biomarkers-in-cardiology\\\/#primaryimage\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/Emerging-Biomarkers-in-Cardiology.jpg\",\"contentUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/Emerging-Biomarkers-in-Cardiology.jpg\",\"width\":1200,\"height\":676},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/emerging-biomarkers-in-cardiology\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Emerging Biomarkers in Cardiology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\",\"name\":\"All About Cardiovascular System and Disorders\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\",\"name\":\"Johnson Francis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"caption\":\"Johnson Francis\"},\"logo\":{\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\"},\"description\":\"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/author\\\/jf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Emerging Biomarkers in Cardiology - All About Cardiovascular System and Disorders","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/johnsonfrancis.org\/professional\/emerging-biomarkers-in-cardiology\/","og_locale":"en_US","og_type":"article","og_title":"Emerging Biomarkers in Cardiology - All About Cardiovascular System and Disorders","og_description":"The landscape of cardiac biomarkers is shifting from simple &#8220;damage detection&#8221; (like Troponin) to &#8220;pathophysiological profiling.&#8221; For a clinician focusing on diagnostics, the most relevant newer biomarkers are those that help phenotype complex conditions like HFpEF, ATTR-CM, and PVC-induced cardiomyopathy. 1. Advanced Heart Failure &amp; Myocardial Remodeling While NT-proBNP remains the workhorse, newer markers provide [&hellip;]","og_url":"https:\/\/johnsonfrancis.org\/professional\/emerging-biomarkers-in-cardiology\/","og_site_name":"All About Cardiovascular System and Disorders","article_published_time":"2026-04-24T11:21:37+00:00","article_modified_time":"2026-04-24T11:21:39+00:00","og_image":[{"width":1200,"height":676,"url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/04\/Emerging-Biomarkers-in-Cardiology.jpg","type":"image\/jpeg"}],"author":"Johnson Francis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Johnson Francis","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/johnsonfrancis.org\/professional\/emerging-biomarkers-in-cardiology\/#article","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/emerging-biomarkers-in-cardiology\/"},"author":{"name":"Johnson Francis","@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"headline":"Emerging Biomarkers in Cardiology","datePublished":"2026-04-24T11:21:37+00:00","dateModified":"2026-04-24T11:21:39+00:00","mainEntityOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/emerging-biomarkers-in-cardiology\/"},"wordCount":558,"publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/emerging-biomarkers-in-cardiology\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/04\/Emerging-Biomarkers-in-Cardiology.jpg","articleSection":["General Cardiology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/johnsonfrancis.org\/professional\/emerging-biomarkers-in-cardiology\/","url":"https:\/\/johnsonfrancis.org\/professional\/emerging-biomarkers-in-cardiology\/","name":"Emerging Biomarkers in Cardiology - All About Cardiovascular System and Disorders","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#website"},"primaryImageOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/emerging-biomarkers-in-cardiology\/#primaryimage"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/emerging-biomarkers-in-cardiology\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/04\/Emerging-Biomarkers-in-Cardiology.jpg","datePublished":"2026-04-24T11:21:37+00:00","dateModified":"2026-04-24T11:21:39+00:00","breadcrumb":{"@id":"https:\/\/johnsonfrancis.org\/professional\/emerging-biomarkers-in-cardiology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/johnsonfrancis.org\/professional\/emerging-biomarkers-in-cardiology\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/johnsonfrancis.org\/professional\/emerging-biomarkers-in-cardiology\/#primaryimage","url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/04\/Emerging-Biomarkers-in-Cardiology.jpg","contentUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/04\/Emerging-Biomarkers-in-Cardiology.jpg","width":1200,"height":676},{"@type":"BreadcrumbList","@id":"https:\/\/johnsonfrancis.org\/professional\/emerging-biomarkers-in-cardiology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/johnsonfrancis.org\/professional\/"},{"@type":"ListItem","position":2,"name":"Emerging Biomarkers in Cardiology"}]},{"@type":"WebSite","@id":"https:\/\/johnsonfrancis.org\/professional\/#website","url":"https:\/\/johnsonfrancis.org\/professional\/","name":"All About Cardiovascular System and Disorders","description":"","publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/johnsonfrancis.org\/professional\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec","name":"Johnson Francis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","caption":"Johnson Francis"},"logo":{"@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g"},"description":"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal","url":"https:\/\/johnsonfrancis.org\/professional\/author\/jf\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/66744","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/comments?post=66744"}],"version-history":[{"count":5,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/66744\/revisions"}],"predecessor-version":[{"id":66758,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/66744\/revisions\/66758"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media\/66746"}],"wp:attachment":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media?parent=66744"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/categories?post=66744"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/tags?post=66744"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}